Venus Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 ,inter alia, to consider and approve Board meeting scheduled for ....
VENUSREM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.8 pts less than Nifty Microcap 250 and 3.0 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Venus Remedies Ltd has notified BSE that a Board meeting is scheduled for 26 May 2026. The meeting will consider and approve the Audited Standalone and Consolidated Financial Results for Q4 and the financial year ended 31 March 2026. The Board will also consider recommending a final dividend for FY 2025-26 and matters related to the ensuing Annual General Meeting. The trading window for designated persons has been closed from 1 April 2026 until 48 hours after the results declaration. This is a routine regulatory intimation and does not contain actual financial numbers.
This is a standard meeting notice and does not provide any financial performance data. Investors should await the actual results announcement for insights into the company's performance. The mention of a potential dividend recommendation could be a positive signal if subsequently approved.